CA Stock MarketDetailed Quotes
PRM Big Pharma Split Corp
- 13.350
- +0.240+1.83%
15min DelayTrading Nov 26 11:51 ET
15.09MMarket Cap13.48P/E (TTM)
13.400High13.350Low500Volume13.400Open13.110Pre Close6.68KTurnover14.57752wk High0.04%Turnover Ratio1.13MShares12.21052wk Low0.99EPS TTM15.09MFloat Cap14.577Historical HighLossP/E (Static)1.13MShs Float5.080Historical Low-0.53EPS LYR0.38%Amplitude1.24Dividend TTM0.95P/B1Lot Size9.27%Div YieldTTM
Big Pharma Split Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q2)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | 300.71%1.59M | -75.07%204.19K | -75.07%204.19K | -56.87%397.51K | -42.71%819.21K | -42.71%819.21K | 50.40%921.57K | 518.99%1.43M | 518.99%1.43M | --612.76K |
| -Cash and cash equivalents | 300.71%1.59M | -75.07%204.19K | -75.07%204.19K | -56.87%397.51K | -42.71%819.21K | -42.71%819.21K | 50.40%921.57K | 518.99%1.43M | 518.99%1.43M | -34.40%612.76K |
| -Available for sale securities | -3.76%25.95M | 7.62%25.54M | 7.62%25.54M | -30.06%26.97M | -32.82%23.73M | -32.82%23.73M | 17.86%38.56M | 57.65%35.32M | 57.65%35.32M | --32.71M |
| Derivative assets | -89.02%42.15K | 31.75%718.24K | 31.75%718.24K | 108.89%383.89K | -32.95%545.14K | -32.95%545.14K | --183.77K | 1,776.69%813K | 1,776.69%813K | --0 |
| Receivables | -29.40%61.51K | -99.45%77.11K | -99.45%77.11K | -37.82%87.12K | 13,546.44%14M | 13,546.44%14M | 50.58%140.11K | -1.57%102.62K | -1.57%102.62K | -96.93%93.05K |
| Total assets | -0.67%27.65M | -32.13%26.53M | -32.13%26.53M | -30.07%27.83M | 3.39%39.1M | 3.39%39.1M | 18.56%39.8M | 64.89%37.81M | 64.89%37.81M | 31.46%33.57M |
| Liabilities | ||||||||||
| Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --539.83K |
| Payables | 189.68%1.11M | -95.94%386.11K | -95.94%386.11K | -47.94%382.94K | 1,636.21%9.51M | 1,636.21%9.51M | 76.76%735.6K | 37.08%547.79K | 37.08%547.79K | -87.07%416.16K |
| -Accounts payable | 0.01%250.54K | -28.51%248.68K | -28.51%248.68K | -27.46%250.51K | 2.60%347.84K | 2.60%347.84K | 14.70%345.34K | 59.00%339.02K | 59.00%339.02K | --301.09K |
| -Total tax payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Other payable | 548.47%858.79K | -98.50%137.43K | -98.50%137.43K | -66.07%132.43K | 4,288.99%9.16M | 4,288.99%9.16M | 239.14%390.26K | 492.27%208.77K | 492.27%208.77K | -96.17%115.07K |
| Other liabilities | 7.34%10.72M | 4.50%10.3M | 4.50%10.3M | -34.04%9.99M | -33.70%9.85M | -33.70%9.85M | 14.70%15.14M | 59.00%14.86M | 59.00%14.86M | --13.2M |
| Total liabilities | 14.08%11.83M | -44.83%10.68M | -44.83%10.68M | -34.69%10.37M | 25.66%19.37M | 25.66%19.37M | 12.15%15.88M | 58.10%15.41M | 58.10%15.41M | 12.64%14.16M |
| Shareholders'equity | ||||||||||
| Total stockholders'equity | -9.42%15.82M | -19.66%15.85M | -19.66%15.85M | -27.01%17.47M | -11.93%19.73M | -11.93%19.73M | 23.24%23.93M | 69.92%22.4M | 69.92%22.4M | 49.69%19.42M |
| Total equity | -9.42%15.82M | -19.66%15.85M | -19.66%15.85M | -27.01%17.47M | -11.93%19.73M | -11.93%19.73M | 23.24%23.93M | 69.92%22.4M | 69.92%22.4M | 49.69%19.42M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data